Australian NMD Registry Consent Form Version[removed]

First Page		Document Content
Date: 2015-02-25 01:48:12 Pharmaceutical industry Muscular dystrophy Clinical trial Design of experiments Pharmacology Disease registry Spinal muscular atrophy TREAT-NMD Duchenne muscular dystrophy Medicine Health Clinical research		Australian NMD Registry Consent Form Version[removed] Add to Reading List Source URL: nmdregistry.com.au Download Document from Source Website File Size: 443,53 KB Share Document on Facebook

	Federal Register / Vol. 82, NoThursday, September 14, Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Center DocID: 1tFAv - View Document
	EXECUTIVE SUMMARY Since 1990, the Agency for Toxic Substances and Disease Registry (ATSDR) has maintained an active, state-based Hazardous Substances Emergency Events Surveillance (HSEES) system to describe the public h DocID: 1tlsH - View Document
	Modelo de acción de la ATSDR ¿Quiénes somos? La Agencia para Sustancias Tóxicas y el Registro de Enfermedades (Agency for Toxic Substances and Disease Registry, ATSDR) es una agencia federal de salud DocID: 1svRg - View Document
	LEAD AND MATERNAL CHILD HEALTH IN THE GLOBAL SOUTH NOTE: This document borrows heavily from the Toxicological Profile for Lead, published by the Agency for Toxic Substances and Disease Registry, 2007. Except where noted, DocID: 1sfcq - View Document
	Microsoft Word - copperChp1FGR10doc DocID: 1rsYs - View Document